Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Latest news
Brain Inflammation Linked to Frontotemporal Dementia
Cardiovascular Drugs, Like Statins, May Reduce Alzheimer’s Risk
Could Psychedelics Help Treat Alzheimer’s?
Dr. Malaz Boustani: The Pros and Cons of Screening for Dementia
Phil’s Journal: My Good Friend Is the First to Receive Biogen’s Alzheimer’s Drug in New Trial
A ‘Medical Emergency’: Experts Project Alzheimer’s Cases Will Triple by 2050
Boosting the Brain’s Metabolism to Fight Alzheimer’s
Harnessing the Brain’s Immune Cells to Remove Amyloid Plaques in Alzheimer’s
Arthena Caston: ‘Living Joyfully’ with Alzheimer’s as an African American
Understanding Traumatic Brain Injury and Dementia Among Military Veterans
Dr. James Ellison: How to Keep People With Dementia Safe From Coronavirus
Study: Early Onset Alzheimer’s Diagnoses Have Tripled
People With Dementia Are at Higher Risk of Coronavirus: Here’s How to Prepare
Biogen Spends $350 Million to Develop Gene Therapies For Alzheimer’s, Parkinson’s
Meet PSEN1: A Newly Discovered Genetic Biomarker for Alzheimer’s
Previous
102
103
104
Next
Page load link
Go to Top